Product Details for ANDA 207667
METHYLPREDNISOLONE SODIUM SUCCINATE (METHYLPREDNISOLONE SODIUM SUCCINATE)
EQ 40MG BASE/VIAL
Marketing Status: Discontinued
EQ 125MG BASE/VIAL
Marketing Status: Discontinued
EQ 500MG BASE/VIAL
Marketing Status: Discontinued
EQ 2GM BASE/VIAL
Marketing Status: Discontinued
EQ 40MG BASE/VIAL
Marketing Status: Discontinued
Active Ingredient: METHYLPREDNISOLONE SODIUM SUCCINATE
Proprietary Name: METHYLPREDNISOLONE SODIUM SUCCINATE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 40MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A207667
Product Number: 001
Approval Date: Dec 15, 2015
Applicant Holder Full Name: EUGIA PHARMA SPECIALITIES LTD
Marketing Status: Discontinued
Patent and Exclusivity Information
METHYLPREDNISOLONE SODIUM SUCCINATE (METHYLPREDNISOLONE SODIUM SUCCINATE)
Proprietary Name: METHYLPREDNISOLONE SODIUM SUCCINATE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 40MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A207667
Product Number: 001
Approval Date: Dec 15, 2015
Applicant Holder Full Name: EUGIA PHARMA SPECIALITIES LTD
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 125MG BASE/VIAL
Marketing Status: Discontinued
Active Ingredient: METHYLPREDNISOLONE SODIUM SUCCINATE
Proprietary Name: METHYLPREDNISOLONE SODIUM SUCCINATE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 125MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A207667
Product Number: 002
Approval Date: Dec 15, 2015
Applicant Holder Full Name: EUGIA PHARMA SPECIALITIES LTD
Marketing Status: Discontinued
Patent and Exclusivity Information
METHYLPREDNISOLONE SODIUM SUCCINATE (METHYLPREDNISOLONE SODIUM SUCCINATE)
Proprietary Name: METHYLPREDNISOLONE SODIUM SUCCINATE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 125MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A207667
Product Number: 002
Approval Date: Dec 15, 2015
Applicant Holder Full Name: EUGIA PHARMA SPECIALITIES LTD
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 500MG BASE/VIAL
Marketing Status: Discontinued
Active Ingredient: METHYLPREDNISOLONE SODIUM SUCCINATE
Proprietary Name: METHYLPREDNISOLONE SODIUM SUCCINATE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 500MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A207667
Product Number: 003
Approval Date: Dec 15, 2015
Applicant Holder Full Name: EUGIA PHARMA SPECIALITIES LTD
Marketing Status: Discontinued
Patent and Exclusivity Information
METHYLPREDNISOLONE SODIUM SUCCINATE (METHYLPREDNISOLONE SODIUM SUCCINATE)
Proprietary Name: METHYLPREDNISOLONE SODIUM SUCCINATE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 500MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A207667
Product Number: 003
Approval Date: Dec 15, 2015
Applicant Holder Full Name: EUGIA PHARMA SPECIALITIES LTD
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 2GM BASE/VIAL
Marketing Status: Discontinued
Active Ingredient: METHYLPREDNISOLONE SODIUM SUCCINATE
Proprietary Name: METHYLPREDNISOLONE SODIUM SUCCINATE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 2GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A207667
Product Number: 004
Approval Date: Dec 15, 2015
Applicant Holder Full Name: EUGIA PHARMA SPECIALITIES LTD
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: METHYLPREDNISOLONE SODIUM SUCCINATE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 2GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A207667
Product Number: 004
Approval Date: Dec 15, 2015
Applicant Holder Full Name: EUGIA PHARMA SPECIALITIES LTD
Marketing Status: Discontinued
Patent and Exclusivity Information